comparemela.com

Latest Breaking News On - George golumbeski - Page 4 : comparemela.com

MorphoSys AG Reports Outcome of Annual General Meeting 2023

EQS-News: MorphoSys AG / Key word: AGM/EGM MorphoSys AG Reports Outcome of Annual General Meeting 2023 17.05.2023 / 22:01 CET/CEST The issuer is solely responsible for the. | May 17, 2023

United statesGeorge golumbeskiEamonn nolanMichael brosnanThomas biegiJulia neugebauerJean paul kressArticles of associationExchange commissionAnnual general meetingSupervisory boardsManagement boardSupervisory boardAuthorized capitalConditional capitalRemuneration report

Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing

Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandAl iskandariyahWhitehead instituteUnited statesHarvard universitySan franciscoCharles gersbachStanley qiCatherine stehman breenJ keith joungAngelo lombardoFyodor urnovLuke gilbertLuigi naldiniJohn maraganore

Former Spark CEO Marrazzo joins epigenetics startup s board

BioPharma

Catherine stehman breenGeorge golumbeskiJohn maraganoreJeff marrazzoAlnylam pharmaceuticalsAtlas ventureSpark therapeuticsRoche owned sparkChroma medicineChroma tuesdayTune therapeuticsEpic bio

Vicinitas Therapeutics Raises $65M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesSouth san franciscoDanielk nomuraChan zuckerberg biohubGeorge golumbeskiKevan shokatJames olzmannJoe budmanThomas maimoneJorge condeCameron wheelerAngela koehlerDaniel marquessUniversity of californiaMolecular therapeutics divisionDepartment of cellular

Novartis-linked startup launches with technology designed to remove destroy tags on helpful proteins

BioPharma

United statesCameron wheelerDaniel nomuraGeorge golumbeskiJorge condeVertex pharmaceuticalsUniversity of californiaNovartis institutes for biomedical researchMark foundation for cancer researchBristol myers squibbBerkeley catalyst fundNovartis institutesBiomedical researchNature chemical biologyDroia venturesMark foundation

vimarsana © 2020. All Rights Reserved.